Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 4/20 | 0.38 |
| ▸ | AR | P10275 | 5/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.35 |
| ▸ | FLT3 | P36888 | 2/20 | 0.34 |
| ▸ | BTK | Q06187 | 2/20 | 0.33 |
| ▸ | LCAT | P04180 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30748741 | 0.87 | ACACB (0.35) | ACACBHRH3KCNH2 | |
| SCHEMBL30749116 | 0.86 | ACACB (0.37) | ACACBARHRH3FLT3BTK | |
| SCHEMBL30748989 | 0.84 | ACACB (0.39) | ACACBARHRH3FLT3BTK | |
| SCHEMBL31691343 | 0.80 | ACACB (0.34) | ACACBARLCAT | |
| SCHEMBL30748997 | 0.79 | ACACB (0.37) | ACACBARHRH3BTKLCAT | |
| SCHEMBL30748804 | 0.76 | ACACB (0.38) | ACACBARHRH3FLT3BTK | |
| SCHEMBL30748874 | 0.75 | CHRM4 (0.45) | ACACBARHRH3BTKLCAT | |
| SCHEMBL30749083 | 0.73 | ACACB (0.38) | ACACBHRH3KCNH2 | |
| SCHEMBL30748722 | 0.71 | TTBK1 (0.38) | — | |
| SCHEMBL30748831 | 0.70 | HRH3 (0.36) | ACACBHRH3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4565588-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | Suzhou Keen Therapeutics Co., Ltd. (CN) | 2025-06-11 | — | — | EP | disclosed |
| WO-2023241620-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) | 2023-12-21 | — | — | WO | disclosed |